Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Human Reproduction

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/humrep/det226PMID 23739218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus on women's health aspects of polycystic ovary syndrome (PCOS).

  2012cited by this paper
• Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome

  2011cited by this paper
• Insulin resistance and the long-term consequences of polycystic ovary syndrome

  2011cited by this paper
• Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age.

  2011cited by this paper
• Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome.

  2011cited by this paper
• No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome

  2011cited by this paper
• Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

  2011cited by this paper
• Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.

  2011cited by this paper
• Insulin resistance and the long-term consequences of polycystic ovary syndrome

  2011cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes

  2010cited by this paper
• Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

  2010cited by this paper
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

  2010cited by this paper
• The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

  2010cited by this paper
• Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

  2009cited by this paper
• ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.

  2009cited by this paper
• Hyperglycemia and Adverse Pregnancy Outcomes

  2009cited by this paper
• Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.

  2008cited by this paper
• Hyperglycemia and adverse pregnancy outcomes.

  2008cited by this paper
• Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.

  2008cited by this paper
• Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

  2007cited by this paper
• Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome.

  2007cited by this paper
• Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.

  2007cited by this paper
• Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome

  2007cited by this paper
• Metabolic syndrome in polycystic ovary syndrome.

  2007cited by this paper
• The metabolic syndrome in polycystic ovary syndrome.

  2007cited by this paper
• Cardiovascular risk in women with polycystic ovary syndrome.

  2007cited by this paper
• PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors

  2006cited by this paper
• A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.

  2006cited by this paper
• Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study.

  2005cited by this paper
• American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome.

  2005cited by this paper
• Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome.

  2004cited by this paper
• Cardiovascular risk in women with polycystic ovary syndrome.

  2001cited by this paper
• Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

  2001cited by this paper
• Cardiovascular disease in women with polycystic ovary syndrome at long‐term follow‐up: a retrospective cohort study

  2000cited by this paper
• Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

  2000cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

  1999cited by this paper
• Mortality of women with polycystic ovary syndrome at long-term follow-up.

  1998cited by this paper
• Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

  1997cited by this paper
• Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women

  1992cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Study on Women with Polycystic Ovary Syndrome and their Health-Related Quality-Of-Life by Confirmatory Analysis

  2024cites this paper
• Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis.

  2024cites this paper
• The role of glycated hemoglobin in the diagnosis of prediabetes and diabetes mellitus in young women with polycystic ovary syndrome

  2023cites this paper
• Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

  2023cites this paper
• PREVALENCE AND CHARACTERISTICS OF THE POLYCYSTIC OVARIAN SYNDROME IN OVERWEIGHT AND OBESE PREMENOPAUSAL WOMEN.

  2022cites this paper
• Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

  2022cites this paper
• Supervised Aerobic Exercise Training and Increased Lifestyle Physical Activity to Reduce Cardiovascular Disease Risk for Women With Polycystic Ovary Syndrome: A Randomized Controlled Feasibility Trial.

  2022cites this paper
• Associations of insulin resistance, sex hormone-binding globulin, triglyceride, and hormonal profiles in polycystic ovary syndrome: A cross-sectional study

  2021cites this paper
• Plasma somatostatin and insulin like growth factor-1 levels in women with polycystic ovary syndrome.

  2020cites this paper
• Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?

  2019cites this paper
• The Estimated Adolescents�Carbohydrate Metabolism and Insulin Resistance in PCOS

  2019cites this paper
• The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome

  2017cites this paper
• СИНДРОМ ПОЛИКИСТОЗНЫХ ЯИЧНИКОВ * ОФИЦИАЛЬНОЕ ЗАЯВЛЕНИЕ ЕВРОПЕЙСКОГО ОБЩЕСТВА ЭНДОКРИНОЛОГИИ (EUROPEAN SOCIETY OF ENDOCRINOLOGY, ESE)

  2015cites this paper
• Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.

  2015influential citation
• The importance of screening for diabetes in women with polycystic ovary syndrome

  2015cites this paper
• Diagnosis and Assessment

  2015cites this paper
• Sexual orientations of women with polycystic ovary syndrome: clinical observation in Taiwan.

  2014cites this paper
• The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

  2014cites this paper
• Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about

  2014cites this paper
• [Importance of the interdisciplinary, evidence-based diagnosis of polycystic ovary syndrome].

  2014cites this paper
• Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?

  2014cites this paper
• Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.

  2014cites this paper
• The utility of fasting plasma glucose to identify impaired glucose metabolism in women with polycystic ovary syndrome

  2014influential citation
• Screening for glycaemic abnormalities in PCOS: an ongoing controversy.

  2013cites this paper
• Diabetes advice for women with polycystic ovary syndrome: prevention, prevention, prevention

  2013cites this paper